investor harm

Class action filed against $CHOW alleging securities fraud, false statements, and undisclosed market-manipulation scheme involving social media misinformation and fraudulent trading.

Class action lawsuit filed against $FCHL alleging materially false statements and fraudulent social media promotion scheme harming investors during September 2025 window.

Class action lawsuit filed against $ATARA alleging securities fraud over false statements regarding manufacturing issues and ALLELE study deficiencies affecting tabelecleucel approval prospects.

Class action lawsuit filed against $SLNO alleging failure to disclose fluid retention safety concerns in DCCR drug trials, harming investors who bought shares March-November 2025.

Class action lawsuit filed against Driven Brands Holdings alleging materially false financial statements, weak internal controls, and accounting discrepancies spanning fiscal 2023-2024.

Class action filed against Babcock & Wilcox alleging undisclosed conflicts in Applied Digital contract and overstated financial prospects. Securities holders from November 2025-March 2026 may be eligible.

Class action filed against $PINS alleging false statements on advertising revenue, tariff impacts, and nondisclosed restructuring from Feb 2025-2026.

Class action lawsuit filed against Lufax Holding Ltd alleging securities fraud and inadequate internal controls. Lead plaintiff deadline set for May 20, 2026.

Class action lawsuit filed against LKQ Corporation alleging executives made false statements about FinishMaster acquisition integration risks and promised strategic benefits.

Class action lawsuit filed against Nektar Therapeutics alleging false statements about REZOLVE-AA trial enrollment protocols. Investors harmed between February-December 2025 can join case.

Class action lawsuit filed against $UHG alleging materially false statements and nondisclosure of controlling shareholder's intentions to force company sale and devalue assets.

Super Micro Computer faces class action lawsuit alleging undisclosed Chinese sales violating U.S. export controls and material compliance weaknesses from February 2024 through March 2026.

Class action lawsuit filed against zSpace alleging false IPO statements regarding preferred shareholders and litigation risks. Lead plaintiff deadline set for June 22, 2026.

Law firm files class action against Regencell Bioscience ($RGC) alleging false statements about market manipulation risks. Investors urged to join case by June 23, 2026 deadline.

Class action lawsuit filed against Gossamer Bio for allegedly concealing design flaws in Phase 3 PROSERA study, claiming investors purchased stock at artificially inflated prices.

Class action lawsuit filed against $AQST alleging securities fraud over false FDA timeline statements and concealed safety risks for Anaphylm drug.

Bronstein, Gewirtz & Grossman files class action against $ATAR, alleging executives misled investors about manufacturing issues and FDA approval prospects for tabelecleucel.

Vital Farms faces class action lawsuit alleging ERP implementation risks were downplayed, leading to missed 2025 earnings guidance and investor losses.

Soleno Therapeutics faces class action lawsuit over allegedly undisclosed fluid retention safety issues with DCCR drug candidate during March-November 2025 period.

Class action lawsuit filed against $UPST alleging false statements about Model 22 AI underwriting capabilities and inflated performance metrics.